Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025)
Akari Therapeutics (AKTX) reported Interest & Investment Income of $1000.0 for Q3 2025, down 66.67% on a YoY basis from $3000.0 in Q3 2024, and little changed sequentially from $1000.0 in Q4 2024.
Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025) Analysis & Trends
Akari Therapeutics (AKTX) has 8 years of Interest & Investment Income data on file, last reported at $1000.0 in Q3 2025.
- For the quarter ending Q3 2025, Interest & Investment Income fell 66.67% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2025 stood at $5000.0 (down 37.5% YoY), and the FY2025 full-year result was $1000.0, down 87.5% from the prior year.
- Interest & Investment Income held at $1000.0 in Q3 2025, from $1000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $30000.0 in Q1 2023 to a low of $1000.0 in Q4 2024.
- A 3-year average of $10111.1 and a median of $3000.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 93.33% in 2024 and tumbled 66.67% in 2025, its largest moves.
- Tracing AKTX's Interest & Investment Income over 3 years: stood at $7000.0 in 2023, then slumped by 85.71% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- Business Quant data shows AKTX's Interest & Investment Income at $1000.0 in Q3 2025, $1000.0 in Q4 2024, and $3000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 26.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2020 | 5,321.00 |
| Sep 30, 2020 | 6,132.00 |
| Jun 30, 2020 | 1,152.00 |
| Mar 31, 2020 | 1,010.00 |
| Dec 31, 2019 | 1,739.00 |
| Sep 30, 2019 | 2,057.00 |
| Jun 30, 2019 | 449.00 |
| Mar 31, 2019 | 1,286.00 |
| Mar 31, 2016 | 30,804.00 |
| Dec 31, 2015 | 19,260.00 |
| Sep 30, 2015 | 1,445.00 |